期刊文献+

5-脱氧杂氮胞苷对HepG2肝癌细胞恶性表型及caspase-3和bcl-2表达的影响 被引量:6

Effect of 5-aza-2′-deoxycytidine on malignant phenotype in HepG2 cells and expression of caspase-3 and bcl-2
下载PDF
导出
摘要 目的 观察5-脱氧杂氮胞苷(5-aza-CdR)对HepG2细胞株生长抑制和凋亡的影响。方法 采用四甲基偶氮唑盐 (MTT)法检测5-aza-CdR对HepG2细胞的生长抑制;通过Giemsa染色观察细胞贴壁克隆形成率;用流式细胞术分析5-aza-CdR对细胞凋亡的影响;用免疫细胞化学方法检测caspase-3和bcl-2蛋白的表达变化。结果 5-aza-CdR可抑制HepG2细胞 株生长,并呈剂量依赖性,第4天时的抑制率最大,可达60.2%,细胞贴壁克隆形成率从36.3%下将至17.3%;流式细胞术结 果表明8μmol/L5-aza-CdR作用第4天凋亡率为10.26%,与对照相比差异有统计学意义;caspase-3蛋白表达明显增加,而 bcl 2蛋白表达则明显下调。结论 5-aza-CdR可抑制HepG2细胞增殖并能促进凋亡,其机制可能是通过恢复某些抑癌基因表 达,上调caspase-3蛋白并下调bcl-2蛋白表达。 Purpose To observe the effect of 5-aza-2′-deoxycytidine on cell growth and apoptosis of HepG2 and the expression of caspase-3 and bcl-2,and to investigate the potential mechanism of its antitumorigenesis. Methods Cell growth inhibition was assayed by MTT method; Colony formation rate was determined by a colony formation experiment in soft agar; Assessment of cell cycle and apoptosis were performed by flow cytometry,and the expression of caspase-3 and bcl-2 were investigated by immunohistochemistry. Results 5-aza-2′-deoxycytidine could inhibit the growth of HepG2 cells in a concentration-dependent manner. 8 μmol/L 5-aza-2′-deoxycytidine could significantly inhibit the cells growth,the inhibitory rate was 60.2% after 96 h. The result of colony formation in soft agar showed that the colony formation rate was significantly dropped from 36.3% to 17.3%,and flow cytometry showed that the rate of apoptosis was 10.26% after treatment by 8 μmol/L 5-aza-2′-deoxycytidine after 96 h. The expression of caspase 3 protein was increased and bcl-2 protein was decreased. Conclusions 5-aza-2′-deoxycytidine can reverse malignant phenotype in HepG2 cells,and the mechanism may be that 5-aza-2′-deoxycytidine restores some tumor suppressor genes expression and increases the expression of caspase 3 while decreased expression of bcl-2.
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2005年第1期103-106,共4页 Chinese Journal of Clinical and Experimental Pathology
关键词 HepG2细胞 CASPASE-3蛋白 bcl-2蛋白表达 恶性表型 BCL-2表达 克隆形成率 肝癌细胞 结论 天时 目的 liver neoplasms 5-aza-2′-deoxycytidine HepG2 protein caspase-3 protein bcl-2
  • 相关文献

参考文献11

  • 1Yang B,Guo M,Herman JG,et al. Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma[J]. Am J Pathol,2003,163(3):1101-7.
  • 2Hui AB,Lo KW,Kwong J,et al. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma[J]. Mol Carcinog,2003,38(4):170-8.
  • 3Astuti D,Da Silva NF,Dallol A, et al. SLIT2 promoter methylation analysis in neuroblastoma,Wilms' tumour and renal cell carcinoma[J]. Br J Cancer,2004,90(2):515-21.
  • 4Shim YH,Park HJ,Choi MS,et al. Hypermethylation of the p16 gene and lack of p16 expression in hepatoblastoma[J]. Mod Pathol,2003,16(5):430-6.
  • 5Herman JG,Latif F,Weng Y, et al. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma[J]. Proc Natl Acad Sci USA,1994,91(21):9700-4.
  • 6Ribeiro-Filho LA,Franks J,Sasaki M,et al. CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer[J]. Mol Carcinog,2002,34(4):187-98.
  • 7Jones PA,Laird PW. Cancer epigenetics comes of age[J]. Nat Genet,1999,21(2):163-7.
  • 8Segura-Pacheco B,Trejo-Becerril C,Perez-Cardenas E, et al. Reactivation of tumor suppressor genes by the cardiovascular drugs hydralazine and procainamide and their potential use in cancer therapy[J]. Clin Cancer Res,2003,9(5):1596-603.
  • 9Krajewska M,Wang HG,Krajewski S,et al. Immunohistochemical analysis of in vivo patterns of expression of CPP32 (caspase-3),a cell death protease[J]. Cancer Res,1997,57(8):1605-13.
  • 10Fujikawa K,Shiraki K,Sugimoto K,et al. Reduced expression of ICE/caspase1 and CPP32/caspase3 in human hepatocellular carcinoma[J]. Anticancer Res,2000,20(3B):1927-32.

同被引文献65

引证文献6

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部